Search Results for: keith baggerly

The Importance of Being Reproducible: Keith Baggerly tells the Anil Potti story

For those Retraction Watch readers who have been following the case of Anil Potti — who has now retracted four papers — Keith Baggerly’s name will likely be familiar. Baggerly is the bioinformatician at M.D. Anderson in Houston who has been publicly questioning, in letters, papers, and The Cancer Letter, work by Potti et. al. … Continue reading The Importance of Being Reproducible: Keith Baggerly tells the Anil Potti story

Update on Anil Potti: A patient in a trial based on retracted research speaks out; Baggerly on how to prevent the next fiasco

A quick post this Sunday morning to draw your attention to two must-read items for anyone interested in the Anil Potti case or in how one goes about checking data. (A second paper by Potti et al was officially retracted on Friday.) First, a terrific profile of Joyce Shoffner in the Charlotte News & Observer. … Continue reading Update on Anil Potti: A patient in a trial based on retracted research speaks out; Baggerly on how to prevent the next fiasco

Weekend reads: Views on the “grievance studies” hoax; universities play “pass the harasser;” what next for NEJM?

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured questions about what should happen to a paper published by … Continue reading Weekend reads: Views on the “grievance studies” hoax; universities play “pass the harasser;” what next for NEJM?

Author with seven retractions makes Thomson Reuters list of top scientists — plus another twist

A cancer researcher who recently retired from MD Anderson Cancer Center —  and also recently lost seven papers from one journal following a multi-year investigation — is one of the world’s top scientists, according to a new ranking. In Thomson Reuters Web of Science’s 2015 list of The World’s Most Influential Scientific Minds, Bharat Aggarwal’s name tops the section … Continue reading Author with seven retractions makes Thomson Reuters list of top scientists — plus another twist

Weekend reads: The end of journals?; Impact Factor for sale; fake peer reviews earn funding bans

This morning, our thoughts are with the people of Paris. The week at Retraction Watch featured the retraction of a paper claiming dramatically higher rates of sexual trauma among men in the military, and a look at whether gender plays a role in peer review. Also: We’re hiring. Here’s what was happening elsewhere:

Study finds many authors aren’t sharing data when they publish — and leads to a PLOS ONE retraction

A new study in Clinical Chemistry paints an alarming picture of how often scientists deposit data that they’re supposed to — but perhaps not surprisingly, papers whose authors did submit such data scored higher on a quality scale than those whose authors didn’t deposit their data. Ken Witwer, a pathobiologist at Hopkins, was concerned that … Continue reading Study finds many authors aren’t sharing data when they publish — and leads to a PLOS ONE retraction

Protein structure retracted after investigation into “highly improbable features,” journal calls it fraud

In 2010, a group of crystallographers immunologists and allergy researchers at the University of Salzburg published a paper in the Journal of Immunology claiming to have derived the structure of a birch pollen allergen. That structure, however, caught the attention of Bernhard Rupp, an eminent crystallographer. In January of this year, Rupp submitted a paper … Continue reading Protein structure retracted after investigation into “highly improbable features,” journal calls it fraud

Potti and colleagues retract 2008 JAMA paper

Anil Potti‘s retraction count is now eight with the withdrawal of a 2008 study in the Journal of the American Medical Association (JAMA). Here’s the notice, which appeared online in JAMA sometime yesterday:

Duke sued over Potti case

From the “not terribly surprising” department: Eight patients — or their estates — who enrolled in clinical trials at Duke overseen by Anil Potti and colleagues have sued the university. The 90-page lawsuit, which names Duke, Potti, Potti’s boss Joseph Nevins, CancerGuide Diagnostics (in which Potti and Nevins had an interest), among others, does a thorough job of documenting … Continue reading Duke sued over Potti case